Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Item No. 16821

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
17-phenyl trinor Prostaglandin F2α (17-phenyl trinor PGF2α) amide is a derivative of the FP receptor agonist 17-phenyl trinor PGF2α ethyl amide (bimatoprost; Item No. 16820) with an unsubstituted amide.1 As with bimatoprost and other prostaglandin amides, the amide of 17-phenyl trinor PGF2α amide may be hydrolyzed to the free acid form in human eyes.2,3,4 Like other amide isomers of F-type prostaglandins, 17-phenyl trinor PGF2α amide may have similar FP receptor activation and intraocular pressure (IOP) reduction activities.3 It has a lower hydrolysis rate in primary human corneas compared to isopropyl ester-protected prodrugs.4
WARNING This product is not for human or veterinary use.
1. Comparison of the ocular hypotensive efficacy of eicosanoids and related compounds. Exp. Eye Res. 38(2), 181-184 (1984).
2. The hydrolysis of the prostaglandin analog prodrug bimatoprost to 17-
3. The pharmacology of bimatoprost (Lumigan™). Surv. Ophthalmol. 45(Suppl. 4), S337-S345 (2001).
4. The hydrolysis of bimatoprost in corneal tissue generates a potent prostanoid FP receptor agonist. Surv. Ophthalmol. 47(Suppl. 1), S34-S40 (2002).
Bimatoprost (Lumiganr) is an agonist at the cloned human ocular FP prostaglandin receptor: Real-